Meeting
2017 ASCO Annual Meeting
Clonal evolution in locally advanced rectal cancers in response to neoadjuvant chemoradiotherapy.
Authors
Sinead Toomey
Department of Molecular Medicine, Royal College of Surgeons in Ireland, Dublin, Ireland
Sinead Toomey , Aoife Carr , Jillian Rebecca Gunther , Joanna Fay , Anthony O'Grady , David Weksberg , Scott W Piraino , Elaine Kay , Brian O'Neill , Sunil Krishnan , Simon J Furney , Bryan Hennessy
Disclaimer
This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org
Poster Details
Session Type
Poster Session
Session Title
Gastrointestinal (Colorectal) Cancer
Track
Gastrointestinal Cancer—Colorectal and Anal
Sub Track
Other Colorectal and Anal Cancer
Citation
J Clin Oncol 35, 2017 (suppl; abstr 3616)
DOI
10.1200/JCO.2017.35.15_suppl.3616
Abstract #
3616
Poster Bd #
239
Abstract Disclosures
Similar Posters
Poster
2018 ASCO Annual Meeting
Predicting treatment outcome of rectal cancer patients underwent neoadjuvant chemoradiotherapy by ctDNA: The potential use of ctDNA monitoring as organ-sparing approach.
First Author: Lifeng Yang
Poster
2017 ASCO Annual Meeting
Phase I study of trametinib with neoadjuvant chemoradiation (CRT) in patients with locally advanced rectal cancers (LARC).
First Author: Christina Sing-Ying Wu
Poster
2014 Gastrointestinal Cancers Symposium
Pretreatment and postresection epidermal growth factor receptor (EGFR) pathway mutations in a prospective phase II trial (EXCITE) of preoperative cetuximab-containing chemoradiation (CRT) in locally advanced rectal cancer (LARC).
First Author: Simon Gollins
Poster
2013 ASCO Annual Meeting
The frequencies and clinical implications of mutations in 33 kinase-related genes in locally advanced rectal cancer.
First Author: Khairun Izlinda Abdul Jalil